Kidney Cancer
Prostate Cancer
EAU Edu Platform on Bladder Cancer
Home
Articles
Article of the Month
Editorial
Videos
Webcasts
Education
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorial
Videos
Webcasts
Education
Terug
E-courses
Webinars
ESOU Online
Clinical problems
Guidelines
Events
Upcoming event
16th European Multidisciplinary Congress on Urological Cancers
Home
/
Videos
Back
EAU24
EAU23
ASCO GU23
EMUC2022
ESMO2022
EAU22
ASCO GU22
EMUC21
EAU 21
ESOU 21
ASCO GU21
EAU20
ESOU Online
ASCO19
EAU19
GU19
EMUC 2018
Surgery
EMUC 2014
ESMO 2014
ERUS 2014
Filter
Tags
5-α reductase inhibitors
,
Androgen antagonists
,
Article of the Month
,
ASCO GU21
,
ASCO GU22
,
ASCO21
,
AUA21
,
BCG
,
BCG therapy
,
BCG-unresponsive disease
,
Bladder neoplasms
,
Bladder-sparing therapy
,
Bladder-sparing trimodality
,
Chemoradiotherapy
,
Clinical pathways
,
Clinical staging
,
Collaborative care
,
Comorbidity
,
Cystectomy
,
Early recurrence patterns
,
EAU21
,
EAU22
,
EMUC21
,
EMUC22
,
EORTC
,
ERBB2
,
ERCC2
,
ESMO21
,
ESOU21
,
ESOU22
,
Gene expression analysis
,
Guidelines
,
Hematuria
,
High-risk NMIBC
,
Highlight of the Month
,
Immune checkpoint
,
Immune checkpoint blockade
,
Immunoregulation
,
Immunotherapy
,
Intravesical therapy
,
Laparoscopic radical cystectomy
,
Masterclass
,
Masterclass on MIBC
,
Masterclass on NMIBC
,
Meta-analysis
,
Metastatic urothelial cancer
,
MIBC
,
Microscopic haematuria
,
Molecular subtypes
,
Multiparametric MRI
,
Neoadjuvant
,
Neoadjuvant chemotherapy
,
Neoplasm recurrence
,
Nephroureterectomy
,
NIBC
,
Non-visible haematuria
,
Nuclear matrix protein 22
,
Oncologic outcomes
,
Open radical cystectomy
,
Optical coherence
,
PD-L1
,
Pembrolizumab
,
PET
,
PLND
,
Postoperative complications
,
POUT trial
,
Prevention & control
,
Quality of life
,
Radical cystectomy
,
Radio-chemotherapy
,
Randomized controlled trial
,
RARC
,
RAZOR Trial
,
Recurrence
,
Robotic
,
Robotic prostatectomy
,
Robotic radical cystectomy
,
Robotic surgery
,
Surgical video
,
Surgical videos
,
Systematic review
,
Tomography
,
Transitional cell
,
Transitional cell carcinoma
,
Tregs
,
Urinary bladder neoplasms
,
Urinary diversion
,
Urological surgery
,
UROonco24
,
Urothelial cancer
,
Urothelium
,
UROwebinar
,
UTUC
,
Webinar
Show all
Round-table discussion on PARP inhibitor
Watch now
Very high risk non-muscle-invasive bladder cancer (NMIBC) in the current landscape of NMIBC
Watch now
The evolving landscape in the management of high-risk non-muscle-invasive bladder cancer
Watch now
New treatment of non-muscle-invasive bladder cancer
Watch now
Safety and efficacy of the erdafitinib intravesical delivery system: Phase 1: first-in-human study
Watch now
Randomized phase III clinical trial of neoadjuvant intravesical mitomycin C treatment
Watch now
Trial to evaluate feasibility & safety of intramural injection of belzupacap sarotalocan in NMIBC
Watch now
Results of European consensus guidelines of oligometastatic bladder cancer (OMBC)
Watch now
eBLOC (en-bloc vs conventional resection of primary bladder tumor) trial
Watch now
First results from BladderPath study
Watch now
RACE IT trial
Watch now
Overall survival (OS) by circulating tumor DNA (ctDNA) status in patients with post-operative muscle-invasive urothelial carcinoma (MIUC) treated with atezolizumab (atezo): update from IMvigor010
Watch now
Previous
Next